McIlrath & Eck’s S&P Global SPGI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$37K Hold
87
﹤0.01% 636
2025
Q4
$45.5K Hold
87
﹤0.01% 364
2025
Q3
$42.3K Hold
87
﹤0.01% 357
2025
Q2
$45.9K Hold
87
0.01% 331
2025
Q1
$44.2K Hold
87
0.01% 340
2024
Q4
$43.3K Sell
87
-10
-10% -$5.07K 0.01% 349
2024
Q3
$50.1K Sell
97
-26
-21% -$12.9K 0.01% 311
2024
Q2
$54.9K Hold
123
0.01% 258
2024
Q1
$52.3K Hold
123
0.01% 265
2023
Q4
$54.2K Hold
123
0.01% 248
2023
Q3
$44.9K Hold
123
0.01% 277
2023
Q2
$49.3K Sell
123
-24
-16% -$8.77K 0.01% 260
2023
Q1
$50.7K Buy
147
+35
+31% +$12.3K 0.01% 248
2022
Q4
$37.5K Hold
112
0.01% 298
2022
Q3
$34K Hold
112
0.01% 319
2022
Q2
$38K Hold
112
0.01% 288
2022
Q1
$46K Buy
112
+59
+111% +$24K 0.01% 254
2021
Q4
$25K Buy
53
+21
+66% +$9.61K 0.01% 371
2021
Q3
$14K Hold
32
﹤0.01% 470
2021
Q2
$13K Hold
32
﹤0.01% 483
2021
Q1
$11K Sell
32
-79
-71% -$26.3K ﹤0.01% 472
2020
Q4
$36K Hold
111
0.01% 215
2020
Q3
$40K Hold
111
0.02% 173
2020
Q2
$37K Buy
111
+79
+247% +$23.8K 0.02% 164
2020
Q1
$8K Buy
+32
New +$8.78K ﹤0.01% 347

Other funds holding SPGI

McIlrath & Eck's SPGI Position: Q1 2026 in Review

McIlrath & Eck held its S&P Global (SPGI) position steady in Q1 2026 at 87 shares worth $37K. The position accounts for ﹤0.01% of the portfolio, ranked #636.

McIlrath & Eck first reported a position in SPGI in Q1 2020 and has held it in 25 quarters since. The position peaked at $54.9K in Q2 2024. 2,119 funds tracked by Wall St. Rank hold SPGI as of Q1 2026.

  • McIlrath & Eck held 87 shares of S&P Global worth $37K as of Q1 2026.
  • McIlrath & Eck left its S&P Global share count unchanged in Q1 2026.
  • S&P Global made up ﹤0.01% of McIlrath & Eck's portfolio in Q1 2026, its #636 holding.
  • McIlrath & Eck first reported a position in S&P Global in Q1 2020 and has held it in 25 quarters since.
  • McIlrath & Eck's S&P Global position peaked at $54.9K in Q2 2024.
  • 2,119 funds tracked by Wall St. Rank held S&P Global as of Q1 2026.

Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.